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Abstract
Background: This study was designed to evaluate the protective effects of Arctium lappa L. root extracts (AREs)
from different extraction methods (aqueous, ethanol, chloroform and flavone) on atherosclerosis.
Methods: Quails (Coturnix coturnix) were subjected to high fat diet, with or without one of the four different AREs
or positive control simvastatin. Blood samples were collected before treatment, after 4.5 weeks or ten weeks to assess
lipid profile (Levels of total cholesterol (TC), Triacylglycerol (TG), low-density lipoprotein (LDL) and high-density
lipoprotein (HDL)). After ten weeks, the serum levels of nitric oxide (NO) as well as antioxidant and pro-oxidative
status (Levels of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), nicotinamide
adenine dinucleotide phosphate (NADPH) and glutathione peroxidase (GSH-Px)) were measured. Furthermore, aortas
were collected after ten weeks treatment, aorta lipid contents (TC, TG and LDL) were assessed, and histology was used
to confirm atherosclerotic changes.
Results: The results indicated that high fat diet significantly deteriorated lipid profile and antioxidant status in
quail serum, while all the extracts significantly reverted the changes similar to simvastatin. Aorta lipid profile assessment
revealed similar results. Histology on aortas from quails treated for ten weeks confirmed atherosclerotic changes in high
fat diet group, while the extracts significantly alleviated the atherosclerotic changes similar to simvastatin. Among the
different extracts, flavones fraction exerted best protective effects.
Conclusions: Our data suggest that the protective effects of AREs were medicated via hypolipidemic and anti-oxidant
effects. Underlying molecular mechanisms are under investigation.
Keywords: Arctium lappa L. root extracts, Atherosclerosis, High fat diet, Hypolipidemic effect, Anti-oxidant effect
Background
Cardiovascular diseases are the leading causes of morbidity
and mortality among adult population throughout the
world [1, 2]. Atherosclerosis is the primary cause of cardio-
vascular disease, leading to the occlusion of the arteries,
resulting in ischemia in vital organs such as heart and
brain and subsequent death. The pathogenesis of athero-
sclerosis is a complex and chronic multifactorial process
and remains a popular topic of research. Identified risk
factors are mainly metabolic disorders such as dyslipid-
emia, obesity and diabetes, in which inflammation and
oxidative stress seems to be the common routes to athero-
genesis [3]. The initial step of oxidative-stress induced
damage to endothelium was extensively studied, which
involves macrophage and oxidized low-density lipoprotein
(ox-LDL) [4, 5]. Atherosclerosis have well-characterized
pathological changes include dysfunction of vascular endo-
thelium, differentiation of monocyte into macrophages,
conversion of macrophages into foam cells and prolifera-
tion of smooth muscle cell [4, 5].
The investigation of contributing factors of atheroscler-
osis is an ongoing hot research topic. Hyperlipidemia,
especially hypercholesterolemia was found to play an
important role in the initiation and progression of athero-
sclerosis [2]. Among the negative impacts of hyperlipid-
emias, it has been well characterized that hyperlipidemia
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could induce overproduction of reactive oxygen species in
endothelial cells, smooth muscle cells and macrophages,
subsequently resulting in oxidative stress and lipid
peroxidation in both humans and animals [6, 7]. Thus,
oxidative stress has been implicated in the pathogenesis of
atherosclerosis, as an independent stage of the disease
progression [8].
Arctium lappa L, commonly known as burdock or bar-
dana, is a perennial plant of the Asteraceae (Compositae)
family. It has been reported that the extract and fractions
of Arctium lappa L roots are used for its colitis prophylac-
tic [9], gastro-protective [10], anti-sterility [11], antimicro-
bial [12] and anti-proliferative effects [13, 14]. A recent
study reported the anti-inflammatory and free radical
scavenging activities of Arctium lappa root extracts
(AREs) [15]. The anti-oxidant capability [16] suggested the
protective potential of AREs against atherosclerosis. The
present study utilized high fat diet induced atherosclerosis
model in quail and focused on the protective effects of
AAE on high fat diet induced atherosclerosis. The high fat
diet quail model ad been used in multiple studies [17–19],
features diet induced atherosclerosis and does not require




Arctium lappa L. Root was purchased from Anqiu vege-
table farm center (Weifang, Shandong, China) and identi-
fied by Dr. Jingying Sun (Shandong Academy of Medicine
Pharmacy Institute). Arctium lappa L. is a well established
traditional Chinese medicine herb, since the material used
in this study met the quality standards set by the Shandong
Food and Drug Administration (SDFDA), no further speci-
men deposit was performed. Simvastatin was purchased
from Hainan Pharmaceutical Factory Co., Ltd. (Hainan,
China) (20 mg/Tablet, Batch number: 130406). 1,4-dioxane
was purchased from Tianjin Ruijin Chemicals Co. Ltd.
(Tianjin, China). Isopropyl alcohol (ISO) was obtained
from Tianjin Fuyu Fine Chemical Co., LTD. (Tianjin,
China). Nitric oxide (NO), malondialdehyde (MDA), super-
oxide dismutase (SOD), catalase (CAT), glutathione (GSH),
nicotinamide adenine dinucleotide phosphate (NADPH)
and glutathione peroxidase (GSH-Px) assay kits were pur-
chased from Jiancheng Institute of Biological Engineering
(Nanjing, China).
Preparation of AREs
Preparation of the ethanol extract (AEE)
The dried roots of A. Lappa (0.6 kg) were soaked in 4 L
of 80 % ethanol for 24 h, and then reflux extracted twice
with 80 and 60 % ethanol for 5 h respectively. The
resulting residue was dried and used for next extraction.
The organic solutions were combined and concentrated
under reduced pressure to give 301.8 g of the ethanol
extract. 231.6 g starch was added to facilitate the forma-
tion of powder, resulting in a total of 533.4 g AEE.
Preparation of the aqueous extract (AAE)
The dried pretreated sample was dipped in distilled
water (9 L) and boiled twice for 2 h. The combined
filtrate was then concentrated under reduced pressure
and evaporated to dryness and the yield of the aqueous
extract is 59.1 g. 21.5 g starch was added, resulting in a
total of 80.6 g AAE.
Preparation of the chloroform fraction (ACE)
The dried roots of A. Lappa (10 kg) were reflux
extracted twice with methanol for 5 h. The methanol
solution was contration under reduced pressure to
obtain a residue. The extract was suspended in water
(6 L) and extracted with chloroform (6 L × 3 times). The
resulting fraction was collected and then concentrated in
vacuo to afford 48.3 g the chloroform fraction. 68.6 g
starch was added to form powder. 116.9 g ACE was the
final total yield.
Preparation of the flavones extract (AFE)
The remaining solution from chloroform extract was
heated to evaporate the organic solvent. Cooled solution
was added into column loading-treated Macroporous
resin DM-130 for absorption, and then washed with
water and 10 % ethanol, respectively, to get rid of impur-
ities. The total flavonoids in column was eluted with
80 % ethanol and dried in a vacuum condition until
powder was formed (157.7 g). 17.1 g starch was added to
form a total of 174.8 g AFE.
Identification of the AREs
Extracted AREs were analyzed in a previous study
carried out by our group. Refer to this work for informa-
tion about detailed compositions and identified specific
chemicals in different AREs [20].
Animal treatment and sample collection
Male quails (3 weeks old, body weight about 100 g) were
purchased from Lanke Poultry Breeding Center (Jimo,
Qingdao, China). All experimental protocols were
approved by the Institutional Animal Use and Care
Committee of Qingdao University (Qingdao, China).
Quails were kept on a 12 h day/night lighting schedule
and had access to standard quail chow and water ad
libitum. After one week environment adaption, the quails
were randomly divided into treatment groups. Due to
limited handling capacity, two separated batches were
used. First batch included: control group, model group,
positive control group and AAE groups (AAE 0.75, 1.5
or 3 g/kg/day); second batch included: control group,
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model group, positive control group, AEE groups (AEE 1
or 2 g/kg/day), ACE groups (ACE 100 or 200 mg/kg/day)
and AFE groups (150 or 300 mg/kg/day). Quails in the
control group were fed standard chow (0 % cholesterol).
Quails in all other groups were fed with high fat diet (1 %
cholesterol and 14 % pork oil, w/w), along with specified
treatments via gavage. After 4.5 weeks treatment, 2 mL
blood were collected from quail right jugular vein. After
10 weeks treatment, terminal body weights were recorded,
then venous blood sample (3 mL) was taken from the
right jugular vein of each quail. Collected blood samples
were incubated at 37 °C for 10 min and then centrifuged
at 3000 rpm for 10 min, resulting serum samples were
collected and archived at -80 °C until further analysis. The
animals were then sacrificed and aorta were dissected for
further analysis.
Serum lipid profile assessment
Serum collected at the beginning of the experiment,
after 4.5 weeks treatment and after ten weeks treatment
were subjected to automatic biochemistry analyzer
Beckman AU5400 (Brea, CA, US) for serum lipid profile
assessment. The levels of serum total cholesterol (TC),
low density lipoprotein (LDL), and high density lipopro-
tein (HDL) were assessed.
Anti-oxidant and pro-oxidative status assessment in
serum
All the biochemical parameters (NO, MDA, SOD, GSH,
NADPH and GSH-Px) were measured with commercial
kits (Nanjing Jiancheng Bioengineering Institute, Jiangsu,
China) following manufacturer’s protocols. All the kits
were based on colorimetric methods, and were carried
out on a spectrophotometer 722E (Shanghai Spectrum
Instruments, Shanhai, China).
Histology of quail aorta
Dissected aortas (aorta arch) were fixed in 4 % formalde-
hyde for 24 h, embedded in paraffin, and then sectioned at
6 μm on a rotary microtome (Leica RM2016, Wetzlar,
Germany). Hematoxylin and eosin (Beyotime, Jiangsu,
China) staining was performed following manufacturer’s
protocol. Pictures were taken with a microscope (Olympus
BX51, Tokyo, Japan) and analyzed with ImageJ (NIH, US).
The ratio of atherosclerotic area to total aorta area was
calculated as an assessment of atherosclerosis.
Transmission electronic microscopy on quail aorta
Dissected aortas were fixed in 5 % glutaraldehyde for 24 h,
dehydrated with graded ethanol, embedded with epoxy
resin 618, sectioned and observed under a transmission
electronic microscope JEM-1200EX (JEOL, Tokyo, Japan).
Aorta lipid profile assessment
Aortas were homogenized in 1 % 1,4-dioxane. Samples
were then incubated in a 37 oC incubator shaker for 72 h.
For each sample, 1 mL of supernatant was collected and
dried, and then dissolved in 50 μL of isopropanol. Lipid
profile was then assessed by subjecting dissolved samples
to automatic biochemical analyzer Beckman AU5400
(Brea, CA, US).
Statistical analysis
Drawing lots method was used to ensure that quails were
randomly assigned into each treatment groups. SPSS 17.0
was used to perform statistical analysis. All data were
expressed as mean ± standard derivation. Normal distribu-
tion was confirmed with Levene’s test, then one-way ana-
lysis of variance (ANOVA) was performed. When P-values
were less than 0.05, the statistical significance was
determined and post-hoc least significant difference (LSD)
tests were performed for the differences among groups.
Table 1 Serum lipid profile of high fat diet-fed quails treated with AAE after four and a half weeks (mM)
Treatment (/kg/day) Total cholesterol Triacylglycerol LDL HDL
Control 5.64 ± 0.79 1.15 ± 0.24 1.41 ± 0.21 3.56 ± 0.46
Model 7.09 ± 0.68a 1.55 ± 0.33a 1.80 ± 0.27a 2.76 ± 0.35a
Simvastatin 15 mg 5.95 ± 0.63b 1.19 ± 0.22b 1.45 ± 0.11b 3.14 ± 0.36b
AAE 0.75 g 6.60 ± 0.41c 1.16 ± 0.31b 1.70 ± 0.17c 3.11 ± 0.29
AAE 1.5 g 6.20 ± 0.46bc 1.09 ± 0.25b 1.58 ± 0.26b 3.18 ± 0.45b
AAE 3 g 5.34 ± 0.37bcde 1.06 ± 0.19b 1.46 ± 0.19bd 3.25 ± 0.48b
astatistically different from control group (P < 0.05)
bstatistically different from model group (P < 0.05)
cstatistically different from simvastatin group (P < 0.05)
dstatistically different from AAE 0.75 g group (P < 0.05)
estatistically different from AAE 1.5 g group (P < 0.05)
Male quails(three weeks old at the beginning of experiments, four weeks old at the beginning of treatments) were subjected to high fat diet (1 % cholesterol and
14 % pork oil, w/w) for a total of ten weeks. Venous blood were collected from right jugular veins after four and a half weeks and ten weeks treatment. Serums
were subjected to automatic biochemistry analyzer Beckman AU5400 (Brea, CA, US) for total cholesterol, triacylglycerol, low density lipoprotein (LDL) and high
density lipoprotein (HDL). Data are shown as mean ± standard derivation, N = 10
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Results
Effect of AREs on serum lipids
To assess the lipid-lowering effect of AREs, serum TG,
TC, LDL and HDL were measured at set time point. After
4.5 weeks of treatment, when compared with control
group, levels of TC, TG and LDL in the high fat diet group
increased significantly, while level of HDL decreased sig-
nificantly. Positive control drug, simvastatin, effectively
reverted all the changes. Low dose (0.75 g/kg/day) AAE
significantly decreased TG level comparing to high fat diet
group, while no significant effect on the levels of TC, LDL
or HDL were found at this dose. However, higher doses
(1.5 and 3 g/kg/day) both significantly decreased TC, TG
and LDL levels and increased HDL levels relative to high
fat diet group (Tables 5, 6, 7 and 8). After 10 weeks of
treatment, the changes in levels of TC, TG, LDL and HDL
further increased in the high fat diet group, while both
simvastatin and AAE at all doses significantly reverted the
changes. At this time point, AAE exhibited a nice dose-
dependent manner for TC and LDL (Tables 1, 2, 3 and 4).
For AEE, ACE and AFE, high fat diet group and
simvastatin group had similar responses, while 4.5 weeks
treatment of AEE, ACE or AFE did not seem to have as
significant hypolipidemic effect as AAE: the only param-
eter seems to be significantly affected was HDL, in
which AEE 2 g/kg, AFE 150 and 300 mg/kg significantly
increased HDL concentration relative to high fat diet
group. When the treatment lasted for ten weeks, both
doses (1 and 2 g/kg) AEE was found effective increasing
HDL content, while only 2 g/kg AEE remarkably
decreased TC, TG and LDL levels. ACE did not seem to
possess hypolipidemic effects since no significant differ-
ence between ACE groups (100 and 200 mg/kg) and
high fat diet group was observed. AFE, on the other
hand, was found to be the most effective one among the
three, effectively decreased TC, TG and LDL levels, and
Table 2 Serum lipid profile of high fat diet-fed quails treated with AAE after ten weeks (mM)
Treatment (g/kg/day) Total cholesterol Triacylglycerol LDL HDL
Control 5.65 ± 0.70 1.10 ± 0.17 1.41 ± 0.20 3.86 ± 0.55
Model 7.79 ± 0.98a 1.79 ± 0.28a 2.03 ± 0.27a 2.47 ± 0.36a
Simvastatin 15 mg 5.75 ± 0.40b 1.13 ± 0.25b 1.49 ± 0.10b 3.37 ± 0.43b
AAE 0.75 g 6.89 ± 0.36bc 1.48 ± 018bc 1.86 ± 0.12bc 3.00 ± 0.28b
AAE 1.5 g 6.10 ± 0.38bcd 1.28 ± 0.28b 1.62 ± 0.23bd 3.45 ± 0.41bd
AAE 3 g 5.14 ± 0.30bcde 1.03 ± 0.20bcde 1.43 ± 0.14bde 3.45 ± 0.52bd
astatistically different from control group (P < 0.05)
bstatistically different from model group (P < 0.05)
cstatistically different from simvastatin group (P < 0.05)
dstatistically different from AAE 0.75 g group (P < 0.05)
estatistically different from AAE 1.5 g group (P < 0.05)
Male quails(three weeks old at the beginning of experiments, four weeks old at the beginning of treatments) were subjected to high fat diet (1 % cholesterol and
14 % pork oil, w/w) for a total of ten weeks. Venous blood were collected from right jugular veins after four and a half weeks and ten weeks treatment. Serums
were subjected to automatic biochemistry analyzer Beckman AU5400 (Brea, CA, US) for total cholesterol, triacylglycerol, low density lipoprotein (LDL) and high
density lipoprotein (HDL). Data are shown as mean ± standard derivation, N = 10
Table 3 Serum lipid profile of high fat diet-fed quails treated with AEE, ACE or AFE after four and a half weeks (mM)
Treatment (/kg/day) Total cholesterol Triacylglycerol LDL HDL
Control 5.60 ± 0.32 1.07 ± 0.23 1.30 ± 0.35 3.71 ± 0.42
Model 6.69 ± 0.44a 1.74 ± 0.27 a 1.95 ± 0.22a 2.30 ± 0.32a
Simvastatin 15 mg 5.72 ± 0.36b 1.37 ± 0.18 b 1.37 ± 0.38b 3.61 ± 0.44b
AEE 1 g 6.57 ± 0.51c 1.53 ± 0.35 1.88 ± 0.24 2.53 ± 0.90c
AEE 2 g 6.58 ± 0.45c 1.85 ± 0.51c 1.84 ± 0.39 2.84 ± 0.43bc
ACE 100 mg 6.32 ± 0.75c 1.59 ± 0.46 1.89 ± 0.15 2.75 ± 0.38c
ACE 200 mg 6.71 ± 0.50c 1.66 ± 0.23 1.81 ± 0.28 2.69 ± 0.38c
AFE 150 mg 6.62 ± 0.52c 1.63 ± 0.44 1.88 ± 0.39 2.80 ± 0.66bc
AFE 300 mg 6.51 ± 0.49c 1.60 ± 0.50 1.91 ± 0.48 2.87 ± 0.46bc
astatistically different from control group (P < 0.05)
bstatistically different from model group (P < 0.05)
cstatistically different from simvastatin group (P < 0.05)
Male quails(three weeks old at the beginning of experiments, four weeks old at the beginning of treatments) were subjected to high fat diet (1 % cholesterol and
14 % pork oil, w/w) for a total of ten weeks. Venous blood were collected from right jugular veins after four and a half weeks and ten weeks treatment. Serums
were subjected to automatic biochemistry analyzer Beckman AU5400 (Brea, CA, US) for total cholesterol, triacylglycerol, low density lipoprotein (LDL) and high
density lipoprotein (HDL). Data are shown as mean ± standard derivation, N = 10
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increased HDL levels. The effects on TG and HDL levels
were dose-dependent (Tables 1, 2, 3 and 4).
Antioxidant effect of AREs
To evaluate the direct effect of AREs on high fat diet in-
duced oxidative stress, the levels of NO, MDA, SOD,
GSH, NADPH and GSH-Px in serums of treated quails
were assessed, and the results were reported in Tables 5,
6, 7 and 8. High fat diet significantly increased MDA
levels and decreased NO, SOD, GSH, NADPH and
GSH-Px levels relative to control group. Simvastatin ef-
fectively reverted these changes. For AAE, lowest dose
(0.75 g/kg) did not significantly affect NO or SOD levels,
but remarkably decreased MDA levels and increased
GSH, NADPH and GSH-Px levels. Higher doses (1.5
and 3 g/kg) significantly decreased MDA levels while
increased NO, GSH, NADPH and GSH-Px levels. For
AEE, ACE and AFE, all the three at all doses tested sig-
nificantly decreased MDA levels while increased NO,
SOD, GSH, NADPH and GSH-Px levels.
Effect of treatment on terminal body weight
No significant differences were observed among control,
high diet and AREs treatment groups. The only group
had a significant decrease in body weight was the simva-
statin group (Fig. 1).
Effect of AREs on aortic morphology
The histology studies displayed that quails fed the normal
diet had no significant endometrial lesions, the inner
Table 4 Serum lipid profile of high fat diet-fed quails treated with AEE, ACE or AFE after ten weeks (mM)
Treatment (/kg/day) Total cholesterol Triacylglycerol LDL HDL
Control 5.51 ± 0.59 1.11 ± 0.13 1.15 ± 0.22 4.10 ± 0.47
Model 7.42 ± 0.57a 1.84 ± 0.37 a 1.88 ± 0.22a 2.42 ± 0.34a
Simvastatin 15 mg 5.69 ± 0.34b 1.14 ± 0.22 b 1.37 ± 0.07b 4.16 ± 0.75b
AEE 1 g 6.34 ± 0.79c 1.67 ± 0.30c 1.99 ± 0.32c 3.28 ± 0.62bc
AEE 2 g 5.96 ± 0.56b 1.21 ± 0.17 bd 1.37 ± 0.22bd 3.62 ± 0.47bc
ACE 100 mg 7.20 ± 0.71c 1.72 ± 0.38c 1.80 ± 0.52c 2.60 ± 0.46c
ACE 200 mg 6.90 ± 0.80c 1.48 ± 0.45 c 1.67 ± 0.36c 2.63 ± 0.38c
AFE 150 mg 6.04 ± 0.70b 1.33 ± 0.31 b 1.51 ± 0.21b 3.11 ± 0.96bc
AFE 300 mg 5.87 ± 0.50b 1.06 ± 0.18 be 1.31 ± 0.19b 3.78 ± 0.41bce
astatistically different from control group (P < 0.05)
bstatistically different from model group (P < 0.05)
cstatistically different from simvastatin group (P < 0.05)
dstatistically different from AAE 1 g group (P < 0.05)
estatistically different from AFE 300 mg group (P < 0.05)
Male quails(three weeks old at the beginning of experiments, four weeks old at the beginning of treatments) were subjected to high fat diet (1 % cholesterol and
14 % pork oil, w/w) for a total of ten weeks. Venous blood were collected from right jugular veins after four and a half weeks and ten weeks treatment. Serums
were subjected to automatic biochemistry analyzer Beckman AU5400 (Brea, CA, US) for total cholesterol, triacylglycerol, low density lipoprotein (LDL) and high
density lipoprotein (HDL). Data are shown as mean ± standard derivation, N = 10
Table 5 Nitric oxide content and antioxidant status in high fat
diet-fed quails treated with AAE for ten weeks (Part I)
Treatment (/kg/day) NO(μmol/ml) MDA(nmol/ml) SOD(U/ml)
Control 35.10 ± 7.79 9.21 ± 2.16 215.72 ± 60.74
Model 29.92 ± 6.94* 11.92 ± 3.13* 194.15 ± 62.45*
Simvastatin 15 mg 37.50 ± 4.79# 6.50 ± 1.33# 238.05 ± 53.76#
AAE 0.75 g 32.71 ± 11.27 9.29 ± 3.74# 205.82 ± 67.44
AAE 1.5 g 38.53 ± 9.55# 8.89 ± 3.66# 222.46 ± 70.11#
AAE 3 g 39.14 ± 9.35# 7.51 ± 2.23# 234.73 ± 61.82#
*statistically different from control group (P < 0.05)
#statistically different from model group (P < 0.05)
Male quails (three weeks old at the beginning of experiments, four weeks
old at the beginning of treatments) were subjected to high fat diet (1 %
cholesterol and 14 % pork oil) for a total of ten weeks. After ten weeks, quails
were sacrificed and blood were collected. Nitric oxide (NO), malondialdehyde
(MDA), superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), nicotinamide
adenine dinucleotide phosphate (NADPH) and glutathione peroxidase (GSH-Px)
were measured with commercial kits following manufacturer’s protocols. Data are
expressed as mean± standard derivation, N= 10
Table 6 Nitric oxide content and antioxidant status in high fat










Control 2.05 ± 0.69 3.24 ± 0.76 3.05 ± 0.95 680.65 ± 185.44
Model 1.62 ± 0.64* 2.92 ± 0.83* 2.60 ± 0.85 594.67 ± 169.58*
Simvastatin
15 mg
2.21 ± 0.73# 3.50 ± 1.05# 3.65 ± 1.10# 826.15 ± 185.68#
AAE 0.75 g 2.11 ± 0.57# 3.27 ± 0.74# 5.10 ± 1.05# 785.48 ± 207.43#
AAE 1.5 g 2.03 ± 0.65# 3.39 ± 0.77# 4.70 ± 1.35# 828.43 ± 190.19#
AAE 3 g 2.17 ± 0.85# 3.51 ± 0.83# 3.75 ± 1.20# 814.72 ± 169.22#
*statistically different from control group (P < 0.05)
#statistically different from model group (P < 0.05)
Male quails (three weeks old at the beginning of experiments, four weeks old
at the beginning of treatments) were subjected to high fat diet (1 %
cholesterol and 14 % pork oil) for a total of ten weeks. After ten weeks, quails
were sacrificed and blood were collected. Nitric oxide (NO), malondialdehyde
(MDA), superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), nicotinamide
adenine dinucleotide phosphate (NADPH) and glutathione peroxidase (GSH-Px)
were measured with commercial kits following manufacturer’s protocols. Data are
expressed as mean ± standard derivation, N= 10
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surface of the aorta was morphologically smooth, and thin,
and the endothelial cells were arranged orderly (Fig. 2).
While quails in the high fat diet groups showed athero-
sclerotic leisions, including markedly thickened and rough
endothelium and irregular, proliferated smooth muscle
layers. Both simvastatin and AREs significantly improved
the mophology of high diet fed quail aortas. In quantifica-
tion, the ratio of atherosclerotic area to total aorta area
was significantly decreased by AREs and simvastatin com-
pared with the high fat diet group (Fig. 3). Among differ-
ent AREs, high dose of AAE (3 g/kg) and low dose of AFE
(150 mg/kg) exhibited comparable protective effects as
simvastatin; high dose of AFE (300 mg/kg) treatment re-
sulted in an even greater anti-atherosclerosis effect com-
paring to simvastatin.
Effect of AREs on aortic ultrastructure
Similar to previously reported ultrastructure changes in
atherosclerosis [21], high fat diet resulted in deterior-
ation of ultrastructure of quail aorta under TEM, includ-
ing vacuolation and diminished ultrastructure.
Treatment with AREs effectively improved the ultra-
structure, among which AFE seemed to have the best
protective effects (Fig. 4).
Effect of AREs on aortic lipids
Lipid profile including TC, TG and LDL were assessed
in aorta samples. As shown in Fig. 5 left columns, the
levels of TC, TG and LDL were significantly decreased
by simvastatin as well as all doses of AAE (0.75, 1.5 and
3 g/kg). The hypolipidemic effect of AAE is dose-
dependent. On the other hand, as demonstrated in Fig. 5
right columns, ACE did not seem to have hypolipidemic
effect, actually, it seemed to have limited hyperlipidemic
effect, increased TG level slightly. AEE had no signifi-
cant effect on TG level, but reduced TC level effectively,
though to a much lesser extent comparing to simva-
statin. High dose of AEE (2 g/kg) could also decrease
LDL level. AFE effectively decreased the levels of TC,
TG and LDL, with a similar pattern as AAE.
Discussion
Hypolipidemic effects of AREs
Hyperlipidemia, especially increased TC, TG and LDL
levels, along with decreased HDL level, are major risk
factors for atherosclerosis [22]. Many current drugs, such
as statins, mainly target the blood lipids to prevent/treat
Table 7 Nitric oxide content and antioxidant status in high fat
diet-fed quails treated with AEE, ACE or AFE for ten weeks (Part
I)
Treatment (/kg/kday) NO(μmol/ml) MDA(nmol/ml) SOD(U/ml)
Control 34.89 ± 7.09 9.33 ± 1.43 210.7 ± 25.4
Model 28.54 ± 6.64* 12.13 ± 2.22* 187.1 ± 23.4*
Simvastatin 15 mg 35.79 ± 5.97# 7.87 ± 1.54# 235.5 ± 16.8#
AEE 1 g 34.88 ± 7.12# 9.40 ± 1.31# 215.5 ± 17.7*
AEE 2 g 35.38 ± 5.60# 9.30 ± 1.40# 217.2 ± 18.9*
ACE 100 mg 35.12 ± 5.60# 9.37 ± 1.19# 215.3 ± 20.9*
ACE 200 mg 35.84 ± 6.70# 9.27 ± 1.18# 216.3 ± 20.8*
AFE 150 mg 35.58 ± 7.91# 9.27 ± 1.20# 215.8 ± 17.8*
AFE 300 mg 36.51 ± 7.65# 9.11 ± 1.55# 220.2 ± 22.3*
*statistically different from control group (P < 0.05)
#statistically different from model group (P < 0.05)
Male quails (three weeks old at the beginning of experiments, four weeks old
at the beginning of treatments) were subjected to high fat diet (1 %
cholesterol and 14 % pork oil) for a total of ten weeks. After ten weeks, quails
were sacrificed and blood were collected. Nitric oxide (NO), malondialdehyde
(MDA), superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), nicotinamide
adenine dinucleotide phosphate (NADPH) and glutathione peroxidase (GSH-Px)
were measured with commercial kits following manufacturer’s protocols. Data are
expressed as mean± standard derivation, N= 8
Table 8 Nitric oxide content and antioxidant status in high fat diet-fed quails treated with AEE, ACE or AFE for ten weeks (Part II)
Treatment (/kg/day) CAT(U/ml) GSH(mg/L) NADPH(μmol/ml) GSH-Px(U)
Control 2.05 ± 0.41 3.34 ± 0.78 3.25 ± 0.87 705.5 ± 90. 7
Model 1.68 ± 0.38* 2.98 ± 0.67* 2.68 ± 0.74* 617.3 ± 84.9*
Simvastatin 15 mg 2.17 ± 0.26# 3.53 ± 0.82# 3.64 ± 0.89# 757.4 ± 93.6#
AEE 1 g 2.18 ± 0.31# 3.32 ± 0.79# 3.34 ± 0.93# 710.2 ± 96.8#
AEE 2 g 2.22 ± 0.36# 3.36 ± 0.91# 3.41 ± 0.86# 718.5 ± 109.4#
ACE 100 mg 2.19 ± 0.30# 3.44 ± 0.93# 3.38 ± 0.85# 738.8 ± 90.4#
ACE 200 mg 2.20 ± 0.43# 3.48 ± 0.81# 3.54 ± 0.91# 751.1 ± 89.6#
AFE 150 mg 2.20 ± 0.28# 3.54 ± 0.85# 3.60 ± 0.78# 754.7 ± 78.4#
AFE 300 mg 2.23 ± 0.33# 3.55 ± 0.80# 3.63 ± 0.88# 763.9 ± 87.3#
*statistically different from control group (P < 0.05)
#statistically different from model group (P < 0.05)
Male quails (three weeks old at the beginning of experiments, four weeks old at the beginning of treatments) were subjected to high fat diet (1 % cholesterol
and 14 % pork oil) for a total of ten weeks. After ten weeks, quails were sacrificed and blood were collected. Nitric oxide (NO), malondialdehyde (MDA), superoxide
dismutase (SOD), catalase (CAT), glutathione (GSH), nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione peroxidase (GSH-Px) were measured with
commercial kits following manufacturer’s protocols. Data are expressed as mean ± standard derivation, N = 8
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Fig. 1 Terminal body weights of quails. Four weeks old male quails were fed with high fat diet (1 % cholesterol and 14 % pork oil, w/w) for ten
weeks and then weighed for terminal body weight. a Body weight of quails treated with AAE (N = 11–17). b Body weight of quails treated with
AEE, ACE or AFE (N = 11–17). a: statistically different from control group (P < 0.05)
Fig. 2 Assessment of atherosclerosis in high fat diet fed quails and the effects of AREs. Four weeks old male quails were fed with high fat diet
(1 % cholesterol and 14 % pork oil, w/w) for ten weeks and then aorta were collected, fixed in 4 % formaldehyde for 24 h, then embedded in
paraffin, sectioned transversally on a rotary microtome (Leica RM2016) at 6 μm and stained with hematoxlin and eosin following manufacturer’s
protocol. a Representative pictures of aorta sections stained with hematoxylin and eosin
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atherosclerosis. Among the four AREs tested in the current
study, ACE does not possess significant hypolipidemic
effect and AEE only possess limited effect, while AAE and
AFE possess significant hypolipidemic effects, whose onset
seems to be a bit slower comparing to simvastatin, but with
enough administration duration, the hypolipidemic effects
are comparable to the well-characterized hypolipidemic
agent simvastatin, thus AAE or AFE administration has
the potential to decrease the risk of atherosclerosis.
NO and antioxidant status
NO plays a key role in the pathogenesis of vascular dis-
eases [23, 24]. It is well documented that endothelial
dysfunction caused by lack of endothelium-derived NO
production and/or decreased nitric oxide (NO) bioavail-
ability or activity has been linked to atherosclerosis initi-
ation and progression [25, 26] Moreover, NO deficiency
can directly impair vascular function and structure thus
promote arteriosclerosis [27]. The results from current
study demonstrated that, similar with simvastatin, AREs
(except for 0.75 g/kg AAE) increases NO production sig-
nificantly. Thus, the increase of NO production could
also contribute to the anti-atherosclerosis effect of AAE.
It has been demonstrated that oxidative stress plays a
key role in the initiation and progression of atheroscler-
osis. The generation of oxidative stress may induce vas-
cular disorder and contribute to atherosclerotic plaque
formation [28]. One of the outcome of oxidative stress,
the lipid peroxidation, could damage the cell plasma
membrane and further leads to deletion of cytoplasmic
components and cell death [28]. MDA, an end product
of lipid peroxidation, is considered a critical biomarker
of oxidative stress [29]. Enzymes including SOD, CAT
and GPx, can reduce the ROS level [30–32]. In current
Fig. 3 Quantification of atherosclerosis in high fat diet fed quails and the effects of AREs. Four weeks old male quails were fed with high fat diet
(1 % cholesterol and 14 % pork oil, w/w) for ten weeks and then aorta were collected, fixed in 4 % formaldehyde for 24 h, then embedded in paraffin,
sectioned transversally on a rotary microtome (Leica RM2016) at 6 μm and stained with hematoxlin and eosin following manufacturer’s protocol. HF:
high fat diet group; Sim: simvastatin group. a: statistically different from control group. b: statistically different from high fat diet group. c: statistically
different from simvastatin group. a Quantification of the ratio of the endothelial proliferation area to total aorta area for the AAE treated animals (N = 3).
b Quantification of the ratio of the endothelial proliferation area to total aorta area for the AEE, ACE and AFE treated animals (N = 3). d: statistically
different from AEE 1 g/kg group
Fig. 4 Ultrastructure of quail aorta in high fat diet fed quails and the effects of AREs. Four weeks old male quails were fed with high fat diet (1 %
cholesterol and 14 % pork oil, w/w) for ten weeks and then aorta were collected, fixed in 5 % glutaraldehyde for 24 h, dehydrated with graded
ethanol, embedded with epoxy resin 618 and then sectioned and observed under a transmission electronic microscope JEM-1200EX. a representative
TEM picture of control quail aorta. b representative TEM picture of high fat diet fed quail aorta. c representative TEM picture of AFE 300 mg/kg/d treated
quail aorta
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study, the levels of MDA were significantly increased
after high fat diet, confirming high levels of oxidative
stress. Meanwhile, the levels of anti-oxidant related en-
zymes SOD, CAT and GSH-Px, as well as endogenous
reducing agents GSH and NADPH were significantly de-
creased, further confirming the induction of oxdative
stress by high fat diet. AREs at all doses (except for the
lowest dose on SOD levels) significantly reverted the
changes, decreasing the levels of MDA and increasing
the levels of SOD, CAT, GSH-Px, GSH and NADPH.
Therefore, endogenous antioxidants regulation is a
possible mechanism involved in the anti-atherosclerosis
effects of AREs.
Atherosclerotic changes
Consistent with published results with atrovastatin [33],
both simvastatin and AREs significantly improved the
mophology of high diet fed quail aortas. This is the dir-
ect confirmation that AREs could protect high fat diet
fed quail against atherosclerosis formation in aorta.
Among different AREs, high dose of AAE (3 g/kg) and
low dose of AFE (150 mg/kg) exhibited comparable
Fig. 5 Lipid profile of aorta in high fat diet fed quails and the effects of AREs. Four weeks old male quails were fed with high fat diet (1 % cholesterol
and 14 % pork oil, w/w) for ten weeks and then aorta were collected, lipids were extracted from homogenized aorta tissue with 1,4-dioxane and the
lipid contents were assessed with an automatic biochemical analyzer (Beckman AU5400, Brea, CA, US) . HF: high fat diet group; Sim: simvastatin group.
a: statistically different from control group. b: statistically different from high fat diet group. c: statistically different from simvastatin group.
a Total cholesterol content in aorta for AAE treated animals (N = 10). d: statistically different from AAE 0.75 g/kg group. e: statistically different from AAE
1.5 g/kg group. b Total cholesterol content in aorta for AEE, ACE and AFE treated animals (N = 10). d: statistically different from AFE 150 mg/kg group.
c Triacylglycerol content in aorta for AAE treated animals (N = 10). d: statistically different from AAE 0.75 g/kg group. e: statistically different from AAE
1.5 g/kg group. d Triacylglycerol content in aorta for AEE, ACE and AFE treated animals (N = 10). d: statistically different from ACE 100 mg/kg group. e:
statistically different from AFE 150 mg/kg group. e LDL content in aorta for AAE treated animals (N = 10). d: statistically different from AWE 0.75 g/kg
group. e: statistically different from AWE 1.5 g/kg group. f LDL content in aorta for AEE, ACE and AFE treated animals (N = 10). d: statistically different
from AFE 150 mg/kg group
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protective effects as simvastatin; high dose of AFE
(300 mg/kg) treatment resulted in an even greater anti-
atherosclerosis effect comparing to simvastatin. The pro-
tective effects were further confirmed with TEM results,
in which AFE exerted protective effects for the micro-
structures of aorta. These data indicates great potential
for the AFE fraction to be used as anti-atherosclerosis
agents.
Aorta lipid profile
The lipid contents of aorta directly reflects the amount
of lipid deposition. Technically, the lower aorta lipid
profile is, the less lipid has deposited in the aorta. Our
results indicates that AAE and AFE exerted best hypo-
lipidemic effects among the four AREs tested, which is
consistent with our morphological assessment. Interest-
ingly, AAE seems to be more potent decreasing TC, with
1.5 and 3 g/kg decreased TC even further than simva-
statin did. Meanwhile, high dose AAE (3 g/kg) are about
as potent as simvastatin reducing TG and LDL. The dif-
ferential response in TC and TG/LDL suggests that AAE
are more effective reducing cholesterol other than LDL.
Further mechanistic study is planned to explore this ef-
fect. Another point worth noting is that even ACE,
which did not have any hypolipidemic effect, exhibited
some antiatherosclerosis effect, suggesting the existence
of hypolipidemic effect-independent mechanism, which
might worth further exploration.
Conclusions
To evaluate the protective effects of AAE on high fat
diet induced atherosclerosis, the high fat diet induced
quail atherosclerosis model was successfully established
and used for the investigation. The results revealed that
AAE is effective in protection against high fat diet in-
duced weight gain, improving serum lipid profile (de-
creasing serum LDL, TG and TC levels, increasing
serum HDL level); protecting against oxidative stress
(decreasing MDA level, while increasing SOD, GSH,
GSH-Px and CAT levels), increasing NO levels in serum,
decreasing lipid content in aorta, and decreasing athero-
sclerotic area in the aorta. All these effects indicate that
AAE is a promising agent in the prevention of athero-
sclerosis. The underlying molecular mechanism is cur-
rently under investigation.
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